Terms: = Liver cancer AND PTPN11, CFC, Q06124, 5781, ENSG00000179295, SHP2, MGC14433, SHP-2, BPTP3, PTP-1D, SH-PTP3, NS1, SH-PTP2, PTP2C AND Prognosis
8 results:
1. Tyrosine phosphatase
Chen X; Keller SJ; Hafner P; Alrawashdeh AY; Avery TY; Norona J; Zhou J; Ruess DA
Front Immunol; 2024; 15():1340726. PubMed ID: 38504984
[TBL] [Abstract] [Full Text] [Related]
2. Increased Siglec-9/Siglec-9L interactions on NK cells predict poor HCC prognosis and present a targetable checkpoint for immunotherapy.
Xiao R; Tian Y; Zhang J; Li N; Qi M; Liu L; Wang J; Li Z; Zhang J; Zhao F; Wang T; Tan S; Li C; Wu Z; Yu M; Jiang X; Zhan P; Gao L; Han B; Liu X; Liang X; Ma C
J Hepatol; 2024 May; 80(5):792-804. PubMed ID: 38331327
[TBL] [Abstract] [Full Text] [Related]
3. ACE2 negatively regulates the Warburg effect and suppresses hepatocellular carcinoma progression via reducing ROS-HIF1α activity.
Dong F; Li H; Liu L; Yao LL; Wang J; Xiang D; Ma J; Zhang G; Zhang S; Li J; Jiang SH; Hu X; Chen J; Bao Z
Int J Biol Sci; 2023; 19(8):2613-2629. PubMed ID: 37215979
[TBL] [Abstract] [Full Text] [Related]
4. Concurrent Disruption of the Ras/MAPK and NF-κB Pathways Induces Circadian Deregulation and Hepatocarcinogenesis.
Hanley KL; Liang Y; Wang G; Lin X; Yang M; Karin M; Fu W; Feng GS
Mol Cancer Res; 2022 Mar; 20(3):337-349. PubMed ID: 34810213
[TBL] [Abstract] [Full Text] [Related]
5. Tumorigenic role of YAP in hepatocellular carcinogenesis is involved in shp2 whose function is different in vitro and in vivo.
Kim MK; Park JY; Kang YN
Pathol Res Pract; 2018 Jul; 214(7):1031-1039. PubMed ID: 29699904
[TBL] [Abstract] [Full Text] [Related]
6. TMEM88, CCL14 and CLEC3B as prognostic biomarkers for prognosis and palindromia of human hepatocellular carcinoma.
Zhang X; Wan JX; Ke ZP; Wang F; Chai HX; Liu JQ
Tumour Biol; 2017 Jul; 39(7):1010428317708900. PubMed ID: 28718365
[TBL] [Abstract] [Full Text] [Related]
7. Dual shp2 and Pten Deficiencies Promote Non-alcoholic Steatohepatitis and Genesis of liver Tumor-Initiating Cells.
Luo X; Liao R; Hanley KL; Zhu HH; Malo KN; Hernandez C; Wei X; Varki NM; Alderson N; Chu C; Li S; Fan J; Loomba R; Qiu SJ; Feng GS
Cell Rep; 2016 Dec; 17(11):2979-2993. PubMed ID: 27974211
[TBL] [Abstract] [Full Text] [Related]
8. ptpn11/shp2 overexpression enhances liver cancer progression and predicts poor prognosis of patients.
Han T; Xiang DM; Sun W; Liu N; Sun HL; Wen W; Shen WF; Wang RY; Chen C; Wang X; Cheng Z; Li HY; Wu MC; Cong WM; Feng GS; Ding J; Wang HY
J Hepatol; 2015 Sep; 63(3):651-60. PubMed ID: 25865556
[TBL] [Abstract] [Full Text] [Related]
